Skip to Main Content

Paper Details

CABA-V7: a prospective biomarker selected trial of cabazitaxel treatment in AR-V7 positive prostate cancer patients.
Eur J Cancer
6
2022
Author NameAffiliation
Paul Hamberg
Ronald de WitErasmus MC Cancer Institute, University Medical Center Rotterdam
Stefan SleijferErasmus MC Cancer Institute, University Medical Center Rotterdam
John W M MartensErasmus MC Cancer Institute, University Medical Center Rotterdam
Job van RietErasmus MC Cancer Institute, University Medical Center Rotterdam
Martijn P LolkemaErasmus MC Cancer Institute, University Medical Center Rotterdam
  • 1 - 6

Datasets

Release 1.2